CHFS vs. NXL, NUWE, HSDT, NDRA, TIVC, VRAYQ, VIVE, STRR, ECOR, and IRIX
Should you be buying Nuwellis stock or one of its competitors? The main competitors of Nuwellis include Nexalin Technology (NXL), Nuwellis (NUWE), Helius Medical Technologies (HSDT), ENDRA Life Sciences (NDRA), Tivic Health Systems (TIVC), ViewRay (VRAYQ), Viveve Medical (VIVE), Star Equity (STRR), electroCore (ECOR), and IRIDEX (IRIX).
Nexalin Technology (NASDAQ:NXL) and Nuwellis (NASDAQ:CHFS) are both small-cap business services companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, community ranking, risk, earnings, valuation and institutional ownership.
Nuwellis received 324 more outperform votes than Nexalin Technology when rated by MarketBeat users.
Nexalin Technology has a beta of 5.13, indicating that its share price is 413% more volatile than the S&P 500. Comparatively, Nuwellis has a beta of 1.55, indicating that its share price is 55% more volatile than the S&P 500.
In the previous week, Nexalin Technology had 3 more articles in the media than Nuwellis. MarketBeat recorded 3 mentions for Nexalin Technology and 0 mentions for Nuwellis. Nuwellis' average media sentiment score of 0.00 equaled Nexalin Technology'saverage media sentiment score.
Nuwellis has a net margin of -254.26% compared to Nuwellis' net margin of -3,088.12%. Nuwellis' return on equity of -154.84% beat Nexalin Technology's return on equity.
Nexalin Technology has higher earnings, but lower revenue than Nuwellis. Nexalin Technology is trading at a lower price-to-earnings ratio than Nuwellis, indicating that it is currently the more affordable of the two stocks.
0.7% of Nexalin Technology shares are held by institutional investors. Comparatively, 65.1% of Nuwellis shares are held by institutional investors. 27.7% of Nexalin Technology shares are held by insiders. Comparatively, 0.6% of Nuwellis shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Nexalin Technology beats Nuwellis on 8 of the 13 factors compared between the two stocks.
Get Nuwellis News Delivered to You Automatically
Sign up to receive the latest news and ratings for CHFS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CHFS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Nuwellis Competitors List
Related Companies and Tools
